Literature DB >> 17212784

A designed curved DNA segment that is a remarkable activator of eukaryotic transcription.

Noriyuki Sumida1, Jun-ichi Nishikawa, Haruka Kishi, Miho Amano, Takayo Furuya, Haruyuki Sonobe, Takashi Ohyama.   

Abstract

To identify artificial DNA segments that can stably express transgenes in the genome of host cells, we built a series of curved DNA segments that mimic a left-handed superhelical structure. Curved DNA segments of 288 bp (T32) and 180 bp (T20) were able to activate transcription from the herpes simplex virus thymidine kinase (tk) promoter by approximately 150-fold and 70-fold, respectively, compared to a control in a transient transfection assay in COS-7 cells. The T20 segment was also able to activate transcription from the human adenovirus type 2 E1A promoter with an 18-fold increase in the same assay system, and also activated transcription from the tk promoter on episomes in COS-7 cells. We also established five HeLa cell lines with genomes containing T20 upstream of the transgene promoter and control cell lines with T20 deleted from the transgene locus. Interestingly, T20 was found to activate transcription in all the stable transformants, irrespective of the locus. This suggests that the T20 segment may allow stable expression of transgenes, which is of importance in many fields, and may also be useful for the construction of nonviral vectors for gene therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17212784     DOI: 10.1111/j.1742-4658.2006.05557.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Competence of an artificial bent DNA as a transcriptional activator in mouse ES cells.

Authors:  Jun-ichi Tanase; Tasuku Mitani; Koji Udagawa; Jun-ichi Nishikawa; Takashi Ohyama
Journal:  Mol Biol Rep       Date:  2010-03-20       Impact factor: 2.316

Review 2.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 3.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

Review 4.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

5.  Structural and functional characteristics of S-like ribonucleases from carnivorous plants.

Authors:  Emi Nishimura; Shinya Jumyo; Naoki Arai; Kensuke Kanna; Marina Kume; Jun-ichi Nishikawa; Jun-ichi Tanase; Takashi Ohyama
Journal:  Planta       Date:  2014-04-26       Impact factor: 4.116

6.  Cloning and Characterization of a Human Genomic Sequence that Alleviates Repeat-Induced Gene Silencing.

Authors:  Miki Fukuma; Yuto Ganmyo; Osamu Miura; Takashi Ohyama; Noriaki Shimizu
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

7.  Requirement or exclusion of inverted repeat sequences with cruciform-forming potential in Escherichia coli revealed by genome-wide analyses.

Authors:  Osamu Miura; Toshihiro Ogake; Takashi Ohyama
Journal:  Curr Genet       Date:  2018-02-27       Impact factor: 3.886

8.  Discrimination of DNA and RNA distribution in a mammalian cell by scanning transmission soft X-ray microscopy.

Authors:  Kunio Shinohara; Atsushi Ito; Takuji Ohigashi; Masataka Kado; Shigenobu Toné
Journal:  J Xray Sci Technol       Date:  2018       Impact factor: 1.535

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.